title: Optimal radiotherapy utilisation rate in developing countries: An IAEA study.
abstract: Optimal radiotherapy utilisation rate (RTU) is the proportion of all cancer cases that should receive radiotherapy. Optimal RTU was estimated for 9 Middle Income Countries as part of a larger IAEA project to better understand RTU and stage distribution.
authors.affiliation: International Atomic Energy Agency, Nuclear Applications, Vienna, Austria.
authors.forename: Eduardo
authors.initials: E
authors.lastname: Rosenblatt
authors.affiliation: Ingham Institute for Applied Medical Research, Radiation Oncology, Sydney, Australia. Electronic address: michael.barton@sswahs.nsw.gov.au.
authors.forename: Michael
authors.initials: M
authors.lastname: Barton
authors.affiliation: Queen's Cancer Research Institute, Queen's University, Kingston, Canada.
authors.forename: William
authors.initials: W
authors.lastname: Mackillop
authors.affiliation: International Atomic Energy Agency, Nuclear Applications, Vienna, Austria.
authors.forename: Elena
authors.initials: E
authors.lastname: Fidarova
authors.affiliation: Hospital Mexico, Radiotherapy, San Jose, Costa Rica.
authors.forename: Lisbeth
authors.initials: L
authors.lastname: Cordero
authors.affiliation: National Centre for Radiotherapy and Nuclear Medicine, Radiotherapy, Accra, Ghana.
authors.forename: Joel
authors.initials: J
authors.lastname: Yarney
authors.affiliation: National Cancer Institute, Putrajaya, Malaysia.
authors.forename: Gerard
authors.initials: G
authors.lastname: Lim
authors.affiliation: Lung Center of the Philippines Hospital, Radiation Oncology, Quezon City, Philippines.
authors.forename: Anthony
authors.initials: A
authors.lastname: Abad
authors.affiliation: Radiation Oncology, Oncology Institute Cluj-Napoca, University of Medicine And Pharmacy, Cluj-Napoca, Romania.
authors.forename: Valentin
authors.initials: V
authors.lastname: Cernea
authors.affiliation: Institute of Oncology and Radiology of Serbia, Radiation Oncology, Belgrade, Serbia.
authors.forename: Suzana
authors.initials: S
authors.lastname: Stojanovic-Rundic
authors.affiliation: Institute of Oncology, Radiation Oncology, Ljubljana, Slovenia.
authors.forename: Primoz
authors.initials: P
authors.lastname: Strojan
authors.affiliation: Institut National de Cancer Salah Azaiz, Radiotherapy, Tunis, Tunisia.
authors.forename: Lotfi
authors.initials: L
authors.lastname: Kobachi
authors.affiliation: Hospital Pereira Rossell, Radiotherapy, Montevideo, Uruguay.
authors.forename: Aldo
authors.initials: A
authors.lastname: Quarneti
mesh_terms: D003906:Developing Countries; D006801:Humans; D007182:Income; D009367:Neoplasm Staging; D009369:Neoplasms / Q000473:pathology / Q000532:radiotherapy*
keywords: Middle income countries; Radiotherapy services; Radiotherapy utilisation